{"id":"https://openalex.org/W803574879","doi":null,"title":"[Albiglutide (Eperzan): a new once-weekly agonist of glucagon-like peptide-1 receptors].","display_name":"[Albiglutide (Eperzan): a new once-weekly agonist of glucagon-like peptide-1 receptors].","publication_year":2015,"publication_date":"2015-04-01","ids":{"openalex":"https://openalex.org/W803574879","mag":"803574879","pmid":"https://pubmed.ncbi.nlm.nih.gov/26054173"},"language":"fr","primary_location":{"id":"pmid:26054173","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26054173","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue medicale de Liege","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039563874","display_name":"Andr\u00e9 Jacques Scheen","orcid":"https://orcid.org/0000-0001-9743-4371","observed_orcids":["https://orcid.org/0000-0001-9743-4371"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"A J Scheen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5039563874"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"4","first_page":"207","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/albiglutide","display_name":"albiglutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.921999990940094},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9459999799728394},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8650000095367432},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7680000066757202},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.9039999842643738},{"id":"https://openalex.org/keywords/glucagon-inhibition","display_name":"glucagon inhibition","score":0.8309999704360962},{"id":"https://openalex.org/keywords/gastric-emptying","display_name":"gastric emptying","score":0.968999981880188},{"id":"https://openalex.org/keywords/satiety","display_name":"satiety","score":0.8709999918937683},{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.5289999842643738},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.5699999928474426},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9430000185966492},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.9369999766349792},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8740000128746033},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.48899999260902405}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7520618438720703},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.7304748296737671},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.5810672640800476},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5452708005905151},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5355595946311951},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5112042427062988},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.5039569735527039},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4974978268146515},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.49166804552078247},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4828258454799652},{"id":"https://openalex.org/C2778854520","wikidata":"https://www.wikidata.org/wiki/Q418776","display_name":"Sulfonylurea","level":3,"score":0.4595794081687927},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.4358243942260742},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.36210018396377563},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3054767847061157}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:26054173","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26054173","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue medicale de Liege","raw_type":"English Abstract"},{"id":"mag:2249931099","doi":null,"is_oa":false,"landing_page_url":"https://orbi.ulg.ac.be/bitstream/2268/183156/1/201504_12.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2752738199","display_name":"RMLG. Revue m\u00e9dicale de Li\u00e8ge","issn_l":"0370-629X","issn":["0370-629X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["medline","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322632779","host_organization_name":"Faculte de medecine de l'Universite de Liege","host_organization_lineage":["https://openalex.org/P4322632779"],"host_organization_lineage_names":["Faculte de medecine de l'Universite de Liege"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"RMLG. Revue m\u00e9dicale de Li\u00e8ge","raw_type":null},{"id":"mag:803574879","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26054173","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W34054004","https://openalex.org/W39375871","https://openalex.org/W169596199","https://openalex.org/W829183077","https://openalex.org/W1970905724","https://openalex.org/W1975687628","https://openalex.org/W1987579024","https://openalex.org/W2005874129","https://openalex.org/W2010033044","https://openalex.org/W2019513002","https://openalex.org/W2023695436","https://openalex.org/W2058954571","https://openalex.org/W2063837617","https://openalex.org/W2080002344","https://openalex.org/W2114027444","https://openalex.org/W2120449552","https://openalex.org/W2128825255","https://openalex.org/W2137562839","https://openalex.org/W2242713206","https://openalex.org/W2277401573","https://openalex.org/W2330429556","https://openalex.org/W2768187910"],"related_works":["https://openalex.org/W1975687628","https://openalex.org/W2301861796","https://openalex.org/W2463892125","https://openalex.org/W2118848581","https://openalex.org/W2080002344","https://openalex.org/W2084245396","https://openalex.org/W1976503602","https://openalex.org/W2555729293","https://openalex.org/W2111068175","https://openalex.org/W2013193807"],"abstract_inverted_index":{"Albiglutide":[0,133],"(Eperzan)":[1],"is":[2,13,131,134],"a":[3,36,100,115,124,149,155,163,175],"new":[4],"once-weekly":[5,188],"agonist":[6],"of":[7,18,47,59,76,82,88,95,104,109,144,180,194],"Glucagon-Like":[8],"Peptide-1":[9],"(GLP-1)":[10],"receptors":[11],"that":[12,53],"indicated":[14],"in":[15,43,63,99,117,137,146,160,177],"the":[16,44,178],"treatment":[17],"type":[19,60],"2":[20,61],"diabetes.":[21],"Two":[22],"doses":[23],"are":[24,78],"available,":[25],"30":[26],"mg":[27],"and":[28,73,93,107,145,154,197],"50":[29],"mg,":[30],"to":[31,80,114],"be":[32,185],"injected":[33],"subcutaneously":[34],"once":[35],"week.":[37],"It":[38],"has":[39],"been":[40],"extensively":[41],"evaluated":[42],"HARMONY":[45],"programme":[46],"eight":[48],"large":[49],"randomised":[50],"controlled":[51],"trials":[52],"were":[54],"performed":[55],"at":[56],"different":[57],"stages":[58],"diabetes,":[62],"comparison":[64],"with":[65,123,148,152,162],"placebo":[66],"or":[67,167,182],"an":[68],"active":[69],"comparator.":[70],"The":[71,127],"endocrine":[72],"metabolic":[74],"effects":[75,112],"albiglutide":[77],"similar":[79],"those":[81],"other":[83],"GLP-1":[84],"receptor":[85],"agonists:":[86],"stimulation":[87],"insulin":[89,165,183],"secretion":[90],"(incretin":[91],"effect)":[92],"inhibition":[94],"glucagon":[96],"secretion,":[97],"both":[98],"glucose-dependent":[101],"manner,":[102],"retardation":[103],"gastric":[105],"emptying":[106],"increase":[108,191],"satiety.":[110],"These":[111],"lead":[113],"reduction":[116,176],"glycated":[118],"haemoglobin":[119],"(HbA(1c))":[120],"levels,":[121],"combined":[122],"weight":[125],"reduction.":[126],"overall":[128],"tolerance":[129],"profile":[130],"good.":[132],"currently":[135],"reimbursed":[136],"Belgium":[138],"after":[139],"failure":[140],"(HbA(1c)":[141],">":[142],"7.5%)":[143],"combination":[147,161],"dual":[150],"therapy":[151,196],"metformin":[153],"sulfonylurea":[156,181],"as":[157,159],"well":[158],"basal":[164],"(with":[166],"without":[168],"oral":[169],"antidiabetic":[170],"drugs).":[171],"To":[172],"avoid":[173],"hypoglycaemia,":[174],"dose":[179],"may":[184],"recommended.":[186],"A":[187],"administration":[189],"should":[190],"patient's":[192],"acceptance":[193],"injectable":[195],"improve":[198],"compliance.":[199]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}